RJA
TTOO

Raymond James & Associates’s T2 Biosystems, Inc TTOO Stock Holding History

Raymond James & Associates’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-114
Closed -$570 – 4116
2022
Q4 		$570 Buy
114
+112
+5,600% +$23K ﹤0.01% 3908
2022
Q3 		$1K Buy
+2
New +$1.31K ﹤0.01% 3934

Other funds holding TTOO

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James & Associates's TTOO Position: Q4 2022 in Review

Raymond James & Associates sold out of T2 Biosystems, Inc (TTOO) in Q4 2022, closing a stake of 5 shares — an estimated $1.03K sold.

Raymond James & Associates first reported a position in TTOO in Q2 2018 and held it in 10 quarters. The position peaked at $100K in Q2 2018. 20 funds tracked by Wall St. Rank hold TTOO as of Q4 2022.

  • Raymond James & Associates reported no remaining T2 Biosystems, Inc position as of Q4 2022 after selling out during the quarter.
  • Raymond James & Associates sold 5 T2 Biosystems, Inc shares in Q4 2022, an estimated $1.03K.
  • Raymond James & Associates first reported a position in T2 Biosystems, Inc in Q2 2018 and held it in 10 quarters.
  • Raymond James & Associates's T2 Biosystems, Inc position peaked at $100K in Q2 2018.
  • 20 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2022.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.